Sugi Predict

Sugi Predict / Compounds / Acrylic Acid

Acrylic Acid

Acrylic Acid

SCHEMBL21990689

C=CC(=O)O.C=Cc1ccccc1S(=O)(=O)O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.39
▸ AKT1 P31749 1/20 0.38
▸ TSHR P16473 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ HTT P42858 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ TGM2 P21980 1/20 0.35
▸ MYC P01106 1/20 0.35
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ CA4 P22748 1/20 0.34
▸ TTR P02766 2/20 0.34
▸ GSR P00390 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ FABP4 P15090 1/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ MAPK14 Q16539 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL21990548 0.91 CA1 (0.41) TDP1AKT1TSHRSMN1; SMN2HTT
SCHEMBL15000 0.91 TDP1 (0.44) TDP1TSHRSMN1; SMN2HTTLMNA
SCHEMBL29361804 0.91 TDP1 (0.44) TDP1TSHRSMN1; SMN2HTTLMNA
Benzene SCHEMBL11665509 0.89 TDP1 (0.41) TDP1AKT1TSHRSMN1; SMN2HTT
SCHEMBL6131308 0.89 TDP1 (0.43) TDP1TSHRSMN1; SMN2HTTLMNA
Formaldehyde SCHEMBL10338469 0.89 TDP1 (0.43) TDP1TSHRSMN1; SMN2HTTLMNA
SCHEMBL1806020 0.89 TDP1 (0.43) TDP1TSHRSMN1; SMN2HTTLMNA
SCHEMBL1888655 0.89 TDP1 (0.43) TDP1TSHRSMN1; SMN2HTTLMNA
Ammonia Solution, Strong SCHEMBL142076 0.89 TDP1 (0.43) TDP1TSHRSMN1; SMN2HTTLMNA
SCHEMBL313313 0.89 TDP1 (0.43) TDP1TSHRSMN1; SMN2HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107419367-B A kind of antibacterial acrylic fibre and preparation method thereof 东华大学 2019-08-16 — — CN claimed
US-11459410-B2 High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof TOSOH FINECHEM CORPORATION (JP) 2022-10-04 — — US disclosed
EP-3666753-A1 HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF Tosoh Finechem Corporation (JP) 2020-06-17 — — EP disclosed
US-20200172643-A1 HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF TOSOH FINECHEM CORPORATION (JP) 2020-06-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11459410-B2 High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof SLC7A1, ARSA, STS TDP1 3230/4885AKT1 1965/4885TSHR 2323/4885
US-20200172643-A1 HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF SLC7A1, ARSA, STS TDP1 3230/4885AKT1 1965/4885TSHR 2323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.